Kalaris Therapeutics (KLRS) Invested Capital (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Invested Capital data on record, last reported at $374.5 million in Q3 2020.
- For Q3 2020, Invested Capital rose 964.04% year-over-year to $374.5 million; the TTM value through Sep 2020 reached $374.5 million, up 964.04%, while the annual FY2019 figure was -$51.3 million, N/A changed from the prior year.
- Invested Capital reached $374.5 million in Q3 2020 per KLRS's latest filing, up from -$70.8 million in the prior quarter.
- Across five years, Invested Capital topped out at $374.5 million in Q3 2020 and bottomed at -$70.8 million in Q2 2020.